[Intensive glucose control in type 2 diabetes is beneficial].
Nilsson
Peter M
PM
Institutionen för kliniska vetenskaper, Universitetssjukhuset MAS, Malmö. peter.nilsson@med.lu.se
Attvall
Stig
S
D001786:Blood Glucose / Q000032:analysis; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000209:etiology / Q000517:prevention & control; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D012307:Risk Factors; D016896:Treatment Outcome
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents